Evaluation of Early Administration of Levetiracetam in the Prevention and Treatment Encephalopathy in Septic Shock: Randomized, Double-blind, Placebo-controlled Trial

NCT06851078 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

280

Enrollment

OTHER

Sponsor class

Conditions

Septic Shock

Interventions

DRUG: Levetiracetam IV
OTHER: Placebo control

Sponsor

Assistance Publique - Hôpitaux de Paris